# Influence of Somatuline Autogel 120mg on Post-operative Drainage After Total Mesorectum Excision for Rectumcarcinoma

> **NCT01372007** · PHASE3 · COMPLETED · sponsor: **University Hospital, Ghent** · enrollment: 24 (actual)

## Conditions studied

- Rectal Carcinoma

## Interventions

- **DRUG:** Lanreotide Autogel 120mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01372007
- **Lead sponsor:** University Hospital, Ghent
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2016-10-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01372007

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01372007, "Influence of Somatuline Autogel 120mg on Post-operative Drainage After Total Mesorectum Excision for Rectumcarcinoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01372007. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*